Vanguard Group Inc Nexgel, Inc. Transaction History
Vanguard Group Inc
- $6.57 Trillion
- Q4 2025
A detailed history of Vanguard Group Inc transactions in Nexgel, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 123,061 shares of NXGL stock, worth $235,046. This represents 0.0% of its overall portfolio holdings.
Number of Shares
123,061
Previous 123,609
0.44%
Holding current value
$235,046
Previous $301,000
21.93%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding NXGL
# of Institutions
19Shares Held
565KCall Options Held
0Put Options Held
0-
Morgan Stanley New York, NY87.1KShares$166,3680.0% of portfolio
-
Geode Capital Management, LLC Boston, MA66.4KShares$126,7640.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny63.5KShares$121,1930.0% of portfolio
-
Susquehanna International Group, LLP Bala Cynwyd, PA43.6KShares$83,3250.0% of portfolio
-
Essex Investment Management CO LLC Boston, MA38KShares$72,6040.02% of portfolio
About NEXGEL, INC.
- Ticker NXGL
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 5,572,230
- Market Cap $10.6M
- Description
- NEXGEL, Inc. manufactures high water content, electron beam cross-linked, and aqueous polymer hydrogels and gels. Its products are used for wound care, medical diagnostics, transdermal drug delivery, and cosmetics. The company was formerly known as AquaMed Technologies, Inc. and changed its name to NEXGEL, Inc. in November 2019. NEXGEL, Inc. was...